ABA 0.00% $5.15 abano healthcare group limited

Ann: RELINT: ABA: Ongoing Disclosure Notice - A.C

  1. lightbulb Created with Sketch. 2
    • Release Date: 27/08/13 18:03
    • Summary: RELINT: ABA: Ongoing Disclosure Notice - A.Clarke
    • Price Sensitive: No
    • Download Document  2.03KB
    					
    
    ABA
    27/08/2013 16:03
    RELINT
    
    REL: 1603 HRS Abano Healthcare Group Limited
    
    RELINT: ABA: Ongoing Disclosure Notice - A.Clarke
    
    Ongoing Disclosure Notice
    Disclosure of Directors and Officers Relevant Interests
    Section 19T(2), Securities Markets Act 1988
    
    A Details of director or officer
    Name of director or officer of public issuer:  Alan William CLARKE
    Name of public issuer: Abano Healthcare Group Limited
    Name of related body corporate (if applicable):  N/A
    Position held in public issuer:  Managing Director
    
    B Securities in public issuer or related body corporate to which this
    disclosure relates
    Number, class, and type of securities: 1  (a) 7,370 ordinary shares (total
    holding of 371,580 after the transaction)
      (b) 83 ordinary shares (total holding of 4,172 after the transaction)
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in those securities: 2  (a) Registered holder and
    beneficial owner
      (b) Registered holder and discretionary beneficiary of the Clarke Family
    Trust
    Name of registered holder of those securities 3  (a) Alan William CLARKE
      (b) Alan William CLARKE, Margaret Clare ADAMS and Christopher David ROSS as
    Trustees of The Clarke Family Trust
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition: 4 23 August 2013
    Consideration paid for acquisition: 5  (a) $46,431.72
      (b) $521.29
    If the relevant interest was disposed of--
    Date of disposal: 6  N/A
    Consideration received for disposal: 7 N/A
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acquisition or disposal took place: 8  Issue of shares pursuant to
    participation in the Dividend Reinvestment Plan for the 2013 final dividend
    
    E Total number of transactions this notice relates to: 9  Two
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer: 10  1 February 2013
    
    G Signature
    Signature of director or officer:
    Date of signature:  27 August 2013
    End CA:00240255 For:ABA    Type:RELINT     Time:2013-08-27 16:03:28
    				
 
watchlist Created with Sketch. Add ABA (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.